Navigation Links
Cone-beam CT: Just as useful as MDCT before and after percutaneous vertebroplasty
Date:11/3/2008

Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan. Percutaneous vertebroplasty is a minimally invasive cement augmentation technique to relieve pain in the back that is non-responsive to conservative treatment.

The study included 22 patients who had osteoporotic compression fractures and underwent percutaneous vertebroplasty for treatment. During the study cone-beam CT and MDCT were performed on all patients before and after percutaneous vertebroplasty. Before vertebroplasty, all 75 cortical defects seen on MDCT were also observed on cone-beam CT with 100% sensitivity and specificity. After vertebroplasty, MDCT found cement leakages in 17 disk spaces, 15 paravertebral soft tissues and 12 veins; cone-beam CT identified all cement leakages.

"While there is no gross difference between MDCT and cone-beam CT, cone-beam CT is believed to deliver less radiation," said Akio Hiwatashi, MD, lead author of the study.

Percutaneous vertebroplasty is common throughout the United States and European countries. It is often used when conservative treatments like pain medication, activity limitation, physical therapy and bracing is not enough.

"Patients can be safely evaluated before and after vertebroplasty using the cone-beam CT system. It is a technical advance in image guided intervention," said Dr. Hiwatashi.


'/>"/>

Contact: Heather Curry
hcurry@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Cone-Beam CT faster, potentially more accurate than conventional mammography
2. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
3. A useful imaging modality for monitoring treatment response to hepatocellular carcinoma
4. CT useful and effective when diagnosing patients with large bowel obstruction
5. Researchers find mass media campaigns useful
6. Angina drug potentially useful against heart rhythm disorders
7. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
8. Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients
9. Robotic device appears useful for surgical removal of cancer involving the tonsils
10. PET scans useful for some cancer treatment, but how do patients fare?
11. CAD plus MDCT useful in finding lung nodules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West ... January 1, 2017. The name change aligns the entire company with its ... health care quality. , “We are very proud of the achievements associated with ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , ... and other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger ... vice president of sales. , Litsinger joined Mirixa in 2008 after serving ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: